Expediting Patient-Oriented Research in Canada: Development of Myeloma Canada Research Network (MCRN)

Janet E Dancey

NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

Multiple myeloma and immunoproliferative diseases

Monica M Bertagnolli

Alliance for Clinical Trials in Oncology Operations Center

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Robert L Comis

ECOG-ACRIN Operations Center

Multiple myeloma and immunoproliferative diseases

Robert M Williams

Multiple Myeloma and Cancer Therapies via Largazole Analogs

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Stephanie J Lee

Improving Outcomes Assessment in Chronic Graft versus Host Disease

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Charles D Blanke

SWOG Network Group Operations Center of the NCTN

Multiple myeloma and immunoproliferative diseases

Wendy Cozen

Genome Wide Admixture Scan for Multiple Myeloma in African Americans

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Andrew G Myers

Synthesis and Study of Natural and Non-natural Antiproliferative Agents

Multiple myeloma and immunoproliferative diseases Leukaemia

Hematology and hematologic malignancies Pathology

Daniel M Sullivan

CRM1 INHIBITORS SENSITIZE MULTIPLE MYELOMA CELLS TO TOPOISOMERASE II AND PROTEASOME INHIBITORS

Multiple myeloma and immunoproliferative diseases